Variant report
Variant | nsv581836 |
---|---|
Chromosome Location | chr2:49975135-50011821 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:49997762..49998692-chr2:50371136..50371712,4 | MCF-7 | breast: | |
2 | chr2:49987705..49990073-chr2:50256678..50259583,2 | K562 | blood: | |
3 | chr2:49997735..49998660-chr2:50371421..50371995,2 | MCF-7 | breast: | |
4 | chr2:49997752..49998563-chr2:50629285..50629956,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528338665 | chr2:49976602-49976603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547387327 | chr2:49976611-49976612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565694649 | chr2:49976664-49976665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547054461 | chr2:49976695-49976696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200562259 | chr2:49976705-49976706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536235067 | chr2:49976772-49976773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570253798 | chr2:49976775-49976776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548709244 | chr2:49976782-49976783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191023845 | chr2:49976842-49976843 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78361539 | chr2:49976852-49976853 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539270851 | chr2:49976866-49976867 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558849228 | chr2:49976871-49976872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577633945 | chr2:49976881-49976882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535290090 | chr2:49976907-49976908 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559180674 | chr2:49976921-49976922 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551598109 | chr2:49976925-49976926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553014088 | chr2:49976940-49976941 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182740029 | chr2:49977002-49977003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541458818 | chr2:49977013-49977014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187428848 | chr2:49977027-49977028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575236228 | chr2:49977036-49977037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565671652 | chr2:49977042-49977043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545997793 | chr2:49977053-49977054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564076941 | chr2:49977087-49977088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10171772 | chr2:49977093-49977094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540174080 | chr2:49977098-49977099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190762447 | chr2:49977099-49977100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530063345 | chr2:49977101-49977102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183327275 | chr2:49977109-49977110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553445345 | chr2:49977140-49977141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73930916 | chr2:49977141-49977142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552741085 | chr2:49977179-49977180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188955028 | chr2:49977205-49977206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs193254387 | chr2:49977216-49977217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78968889 | chr2:49977230-49977231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568750227 | chr2:49977241-49977242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535470174 | chr2:49977257-49977258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556651385 | chr2:49977297-49977298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74716293 | chr2:49977347-49977348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184138042 | chr2:49977391-49977392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545536998 | chr2:49977464-49977465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187922967 | chr2:49977495-49977496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572746624 | chr2:49977557-49977558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140665022 | chr2:49977604-49977605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs13403850 | chr2:49977652-49977653 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs529112485 | chr2:49977663-49977664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34046490 | chr2:49977666-49977667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144474805 | chr2:49977675-49977676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191564480 | chr2:49977695-49977696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs41431847 | chr2:49977702-49977703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49976600-49976800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr2:49976800-49977000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:49976800-49980200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr2:49977000-49978200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr2:49978200-49981600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr2:49980000-49981000 | Enhancers | HUVEC | blood vessel |
7 | chr2:49980200-49981600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr2:49980600-49980800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr2:49980600-49981200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr2:49980600-49981600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr2:49980800-49981000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr2:49981000-49981800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:49981600-49982800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr2:49981800-49982200 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr2:49983000-49983200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
16 | chr2:49998000-49998600 | Enhancers | H1 Cell Line | embryonic stem cell |
17 | chr2:49998200-49998600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
18 | chr2:49998200-49998600 | Active TSS | Brain Substantia Nigra | brain |
19 | chr2:50007800-50008800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |